Yongming Qu

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 25

Top Topics

Coronavirus Disease

Top Venues

Pharmaceutical statistics

Statistics in medicine

Therapeutic innovation & regulatory science

This page only lists publications with an associated author ORCID identifier.

Publications

Joseph C Mellor, Dmitry Kuznetsov, Simon R Heller, Mari-Anne Gall, Myriam Rosilio, Stephanie A Amiel, Mark Ibberson, Stuart J McGurnaghan, Luke A K Blackbourn, William Berthon, Adel Salem, Yongming Qu, Rory J McCrimmon, Bastiaan E De Galan, Ulrik Pedersen-Bjergaard, Joanna Leaviss, Paul M McKeigue, Helen Martina Colhoun
Risk factors and prediction of hypoglycaemia using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials. Diabetologia 67 (8) (2024)
Yu Du, Jianghao Li, Sohini Raha, Yongming Qu
A unified Bayesian framework for bias adjustment in multiple comparisons from clinical trials. Statistics in medicine (2024)
Ilya Lipkovich, Bohdana Ratitch, Yongming Qu, Xiang Zhang, Mingyang Shan, Craig Mallinckrodt
Correction to "Using principal stratification in analysis of clinical trials". Statistics in medicine (2024)
Yu Du, Jianghao Li, Sohini Raha, Yongming Qu
A unified Bayesian framework for bias adjustment in multiple comparisons from clinical trials. Statistics in medicine 43 (15) (2024)
Joseph C Mellor, Dmitry Kuznetsov, Simon R Heller, Mari-Anne Gall, Myriam Rosilio, Stephanie A Amiel, Mark Ibberson, Stuart J McGurnaghan, Luke A K Blackbourn, William Berthon, Adel Salem, Yongming Qu, Rory J McCrimmon, Bastiaan E De Galan, Ulrik Pedersen-Bjergaard, Joanna Leaviss, Paul M McKeigue, Helen Martina Colhoun
Risk factors and prediction of hypoglycaemia using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials. Diabetologia 67 (8) (2024)
Yu Du, Jianghao Li, Sohini Raha, Yongming Qu
A unified Bayesian framework for bias adjustment in multiple comparisons from clinical trials. Statistics in medicine 43 (15) (2024)
Joseph C Mellor, Dmitry Kuznetsov, Simon R Heller, Mari-Anne Gall, Myriam Rosilio, Stephanie A Amiel, Mark Ibberson, Stuart J McGurnaghan, Luke A K Blackbourn, William Berthon, Adel Salem, Yongming Qu, Rory J McCrimmon, Bastiaan E De Galan, Ulrik Pedersen-Bjergaard, Joanna Leaviss, Paul M McKeigue, Helen Martina Colhoun
Estimating risk of consequences following hypoglycaemia exposure using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials. Diabetologia (2024)
Joseph C Mellor, Dmitry Kuznetsov, Simon R Heller, Mari-Anne Gall, Myriam Rosilio, Stephanie A Amiel, Mark Ibberson, Stuart J McGurnaghan, Luke A K Blackbourn, William Berthon, Adel Salem, Yongming Qu, Rory J McCrimmon, Bastiaan E De Galan, Ulrik Pedersen-Bjergaard, Joanna Leaviss, Paul M McKeigue, Helen Martina Colhoun
Risk factors and prediction of hypoglycaemia using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials. Diabetologia 67 (8) (2024)
Ilya Lipkovich, Bohdana Ratitch, Yongming Qu, Xiang Zhang, Mingyang Shan, Craig Mallinckrodt
Correction to "Using principal stratification in analysis of clinical trials". Statistics in medicine 43 (8) (2024)
Joseph C Mellor, Dmitry Kuznetsov, Simon R Heller, Mari-Anne Gall, Myriam Rosilio, Stephanie A Amiel, Mark Ibberson, Stuart J McGurnaghan, Luke A K Blackbourn, William Berthon, Adel Salem, Yongming Qu, Rory J McCrimmon, Bastiaan E De Galan, Ulrik Pedersen-Bjergaard, Joanna Leaviss, Paul M McKeigue, Helen Martina Colhoun
Risk factors and prediction of hypoglycaemia using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials. Diabetologia (2024)
Ran Duan, Kaiyi Chen, Yu Du, Pandurang M Kulkarni, Yongming Qu
Non-monotone Exponential Time (NEXT) Model for the Longitudinal Trend of a Continuous Outcome in Clinical Trials. Therapeutic innovation & regulatory science (2023)
Ahmad Hakeem Abdul Wahab, Yongming Qu, Hege Michiels, Junxiang Luo, Run Zhuang, Dominique McDaniel, Dong Xi, Elena Polverejan, Steven Gilbert, Stephen J Ruberg, Arman Sabbaghi
CITIES: Clinical trials with intercurrent events simulator. Biometrical journal. Biometrische Zeitschrift (2023)
Chenchen Ma, Xin Shen, Yongming Qu, Yu Du
Analysis of an incomplete binary outcome dichotomized from an underlying continuous variable in clinical trials. Pharmaceutical statistics 21 (5) (2022)
Yongming Qu, Robin D White, Stephen J Ruberg
Accurate Collection of Reasons for Treatment Discontinuation to Better Define Estimands in Clinical Trials. Therapeutic innovation & regulatory science (2022)
Yongming Qu, Biyue Dai
Return-to-baseline multiple imputation for missing values in clinical trials. Pharmaceutical statistics 21 (3) (2022)
Ilya Lipkovich, Bohdana Ratitch, Yongming Qu, Xiang Zhang, Mingyang Shan, Craig Mallinckrodt
Using principal stratification in analysis of clinical trials. Statistics in medicine 41 (19) (2022)
Yongming Qu, So Young Park, Qiwei Wu, Wei Shen
A unified approach for evaluating the prediction of treatment effect across different types of endpoints. Pharmaceutical statistics (2021)
Yongming Qu, Ilya Lipkovich
Implementation of ICH E9 (R1): A Few Points Learned During the COVID-19 Pandemic. Therapeutic innovation & regulatory science 55 (5) (2021)
Junxiang Luo, Stephen J Ruberg, Yongming Qu
Estimating the treatment effect for adherers using multiple imputation. Pharmaceutical statistics 21 (3) (2021)
Amy LaLonde, Yongming Qu
Estimation of group means using Bayesian generalized linear mixed models. Pharmaceutical statistics 19 (4) (2020)
Yongming Qu, Junxiang Luo, Stephen J Ruberg
Implementation of tripartite estimands using adherence causal estimators under the causal inference framework. Pharmaceutical statistics 20 (1) (2020)
Jiexin Duan, Michael Levine, Junxiang Luo, Yongming Qu
Estimation of group means in generalized linear mixed models. Pharmaceutical statistics 19 (5) (2020)
Yongming Qu, Yu Du, Ying Zhang, Lei Shen
Understanding and adjusting for the selection bias from a proof-of-concept study to a more confirmatory study. Statistics in medicine 39 (30) (2020)
Yongming Qu, Linda Shurzinske, Shanthi Sethuraman
Defining estimands using a mix of strategies to handle intercurrent events in clinical trials. Pharmaceutical statistics 20 (2) (2020)
Yongming Qu
Can a multiple ascending dose study serve as an informative proof-of-concept study? Statistics in medicine 38 (3) (2018)